172 related articles for article (PubMed ID: 2181670)
1. The pathogenesis of autoimmunity in New Zealand mice.
Yoshida S; Castles JJ; Gershwin ME
Semin Arthritis Rheum; 1990 Feb; 19(4):224-42. PubMed ID: 2181670
[No Abstract] [Full Text] [Related]
2. The pathogenesis of autoimmunity in New Zealand black mice.
Talal N; Steinberg AD
Curr Top Microbiol Immunol; 1974; 64(0):79-103. PubMed ID: 4276856
[No Abstract] [Full Text] [Related]
3. [Pathogenic mechanisms of autoimmune diseases].
Bonnotte B
Rev Med Interne; 2004 Sep; 25(9):648-58. PubMed ID: 15363620
[TBL] [Abstract][Full Text] [Related]
4. The use of immunologic mutations as probes of cellular interactions and autoimmunity in New Zealand mice.
Bray KR; Gershwin ME
Exp Cell Biol; 1984; 52(1-2):85-96. PubMed ID: 6141962
[No Abstract] [Full Text] [Related]
5. Autoimmunity and lymphoid malignancy in New Zealand black mice.
Talal N
Prog Clin Immunol; 1974; 2():101-20. PubMed ID: 4141778
[No Abstract] [Full Text] [Related]
6. In vitro suppression of cell mediated autoimmunity in NZB mice.
Russell AS; Liburd EM; Diener E
Nature; 1974 May; 249(452):43-5. PubMed ID: 4545401
[No Abstract] [Full Text] [Related]
7. [The etiology and pathogenesis of autoimmune diseases].
Efuni SS
Gematol Transfuziol; 1993 Apr; 38(4):32-7. PubMed ID: 8026672
[No Abstract] [Full Text] [Related]
8. Splenic immunoglobulin-secreting cells and their regulation in autoimmune mice.
Theofilopoulos AN; Shawler DL; Eisenberg RA; Dixon FJ
J Exp Med; 1980 Feb; 151(2):446-66. PubMed ID: 6444324
[TBL] [Abstract][Full Text] [Related]
9. Activation of T and B lymphocytes in NZB mice.
Cohen PL; Ugai K; Ligler FS
J Clin Lab Immunol; 1982 Dec; 9(3):199-205. PubMed ID: 6132011
[TBL] [Abstract][Full Text] [Related]
10. Terminal deoxynucleotidyl transferase deficiency reduces the incidence of autoimmune nephritis in (New Zealand Black x New Zealand White)F1 mice.
Conde C; Weller S; Gilfillan S; Marcellin L; Martin T; Pasquali JL
J Immunol; 1998 Dec; 161(12):7023-30. PubMed ID: 9862739
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of autoimmunity in New Zealand mice. V. Loss of thymic suppressor function.
Steinberg AD
Arthritis Rheum; 1974; 17(1):11-4. PubMed ID: 4149328
[No Abstract] [Full Text] [Related]
12. A comparative immunologic analysis of several murine strains with autoimmune manifestations.
Theofilopoulos AN; McConahey PJ; Izui S; Eisenberg RA; Pereira AB; Creighton WD
Clin Immunol Immunopathol; 1980 Mar; 15(3):258-78. PubMed ID: 6445246
[No Abstract] [Full Text] [Related]
13. Silent antibodies.
Bouvet JP; Zouali M
Arch Inst Pasteur Tunis; 2005; 82(1-4):3-8. PubMed ID: 16929749
[TBL] [Abstract][Full Text] [Related]
14. The immunologic basis of autoimmunization.
Schwartz RS
J Allergy Clin Immunol; 1977 Jul; 60(1):69-72. PubMed ID: 326848
[No Abstract] [Full Text] [Related]
15. [The thymus gland and autoimmune diseases].
Klug H
Z Gesamte Inn Med; 1973 Aug; 28(15):441-50. PubMed ID: 4587798
[No Abstract] [Full Text] [Related]
16. Thymus-antigen- and immunoglobulin-positive lymphocytes in tissue infiltrates of NZB/NZW mice.
Greenspan JS; Gutman GA; Weissman IL; Talal N
Clin Immunol Immunopathol; 1974 Sep; 3(1):16-31. PubMed ID: 4611670
[No Abstract] [Full Text] [Related]
17. MHC heterozygosity and autoimmunity.
Kimoto M; Nishimura H; Hirose S; Shirai T
Immunol Today; 1993 Nov; 14(11):569-70. PubMed ID: 8274200
[No Abstract] [Full Text] [Related]
18. Regulation of autoimmunity.
Kumar V; Sercarz EE
Curr Opin Immunol; 1991 Dec; 3(6):888-95. PubMed ID: 1793531
[TBL] [Abstract][Full Text] [Related]
19. Regulatory T cells as central regulators of both autoimmunity and B cell malignancy in New Zealand Black mice.
Scaglione BJ; Salerno E; Gala K; Pan M; Langer JA; Mostowski HS; Bauer S; Marti G; Li Y; Tsiagbe VK; Raveche ES
J Autoimmun; 2009 Feb; 32(1):14-23. PubMed ID: 19022624
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in autoimmunity.
Krakauer RS; Clough JD; Ilfeld D
Cleve Clin Q; 1980; 47(2):73-7. PubMed ID: 6994934
[No Abstract] [Full Text] [Related]
[Next] [New Search]
